Expect Intensified M&A Activity with Bio-Pharmaceutical Companies Leading to an Active 2021 & Beyond

Expect Intensified M&A Activity with Bio-Pharmaceutical Companies Leading to an Active 2021 & Beyond

While life sciences-focused mergers and acquisition activity in 2020 was expected to dip, at least a bit due to the pandemic—as compared to 2019 pace—this turned out not to be the case at all. There is an intense race to develop vaccines and therapies targeting the novel coronavirus and with governments pumping money into subsidized ongoing efforts, such as the approximately $15+ billion put into just several firms thanks to the U.S. Government (Operation Warp Speed, BARDA, NIH, DOD, etc.). This primed the pump for intense deal making in 2020, a white hot year despite a horrific pandemic. Moreover, the ongoing and underlying fundamentals for health care sectoral growth continue unabated if not intensified by the pandemic, from aging populations, growing numbers of chronic conditions, greater incomes in places such as Asia and India, to ongoing technological (including biologic) innovation from gene editing and targeted regenerative therapy to the impact of artificial intelligence in the drug discovery process. Frankly, an eruption of innovation coupled with vast pools of capital and many restless, well-capitalized companies (“Pharma”) seeking competitive advantage will m...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee